The Latest
-
What Kind Of Investors Own Most Of Axsome Therapeutics, Inc. (NASDAQ:AXSM)?
-
Tesla could hit $2,000 in best-case scenario, says analyst
-
Gundlach lashes Fed’s ‘incredible fiscal lending’ during coronavirus collapse
-
Treasury and five major airlines finalize loan terms